Results
1355
Companies which are more than 50% undervalued based on analyst price target.
1355 companies
Marvell Technology
Market Cap: US$53.1b
Provides data infrastructure semiconductor solutions, spanning the data center core to network edge.
MRVL
US$60.11
7D
-8.8%
1Y
-18.4%
JD.com
Market Cap: US$48.9b
Operates as a supply chain-based technology and service provider in the People’s Republic of China.
JD
US$33.65
7D
-5.8%
1Y
3.0%
Warner Bros. Discovery
Market Cap: US$22.8b
Operates as a media and entertainment company worldwide.
WBD
US$8.95
7D
-2.8%
1Y
11.0%
Market Cap: US$19.5b
Operates a digital community in the United States and internationally.
RDDT
US$95.85
7D
-23.5%
1Y
69.1%
Kaspi.kz
Market Cap: US$15.7b
Provides payments, marketplace, and fintech solutions for consumers and merchants in Kazakhstan, Azerbaijan, and Ukraine.
KSPI
US$80.85
7D
-1.5%
1Y
-31.5%
Alexandria Real Estate Equities
Market Cap: US$12.5b
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world.
ARE
US$68.57
7D
-3.4%
1Y
-44.2%
BioMarin Pharmaceutical
Market Cap: US$11.5b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$58.48
7D
-0.4%
1Y
-23.5%
Aurora Innovation
Market Cap: US$11.1b
Operates as a self-driving technology company in the United States.
AUR
US$6.06
7D
-11.7%
1Y
139.5%
Moderna
Market Cap: US$10.8b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$25.80
7D
7.4%
1Y
-84.2%
SailPoint
Market Cap: US$9.9b
SailPoint, Inc. delivers solutions to enable identity security for the enterprise in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.
SAIL
US$17.18
7D
-9.5%
1Y
n/a
Sociedad Química y Minera de Chile
Market Cap: US$9.8b
Operates as a mining company worldwide.
SQM
US$33.50
7D
-6.6%
1Y
-29.5%
GitLab
Market Cap: US$8.3b
Develops software for the software development lifecycle in the United States, Europe, and the Asia Pacific.
GTLB
US$47.60
7D
-10.9%
1Y
-17.1%
VinFast Auto
Market Cap: US$8.3b
Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.
VFS
US$3.53
7D
-2.5%
1Y
-24.4%
AST SpaceMobile
Market Cap: US$8.2b
Designs and develops the constellation of BlueBird satellites in the United States.
ASTS
US$23.83
7D
-9.2%
1Y
411.9%
Corcept Therapeutics
Market Cap: US$8.1b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$75.80
7D
7.0%
1Y
164.8%
Roivant Sciences
Market Cap: US$7.9b
A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.
ROIV
US$10.91
7D
2.2%
1Y
-3.4%
Bio-Techne
Market Cap: US$7.8b
Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
TECH
US$46.66
7D
-2.5%
1Y
-43.8%
Revolution Medicines
Market Cap: US$7.5b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$38.74
7D
-1.9%
1Y
-2.6%
Repligen
Market Cap: US$7.2b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$120.21
7D
-6.1%
1Y
-27.2%
Jazz Pharmaceuticals
Market Cap: US$6.8b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$108.27
7D
1.6%
1Y
2.6%
UWM Holdings
Market Cap: US$6.8b
Engages in the origination, sale, and servicing residential mortgage lending in the United States.
UWMC
US$3.97
7D
-3.6%
1Y
-43.4%
Madrigal Pharmaceuticals
Market Cap: US$6.5b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$277.24
7D
-2.0%
1Y
17.9%
BridgeBio Pharma
Market Cap: US$6.4b
A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.
BBIO
US$32.84
7D
-2.4%
1Y
12.2%
Caesars Entertainment
Market Cap: US$6.1b
Operates as a gaming and hospitality company.
CZR
US$27.96
7D
-8.9%
1Y
-19.5%
Bruker
Market Cap: US$5.8b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$36.45
7D
-1.1%
1Y
-53.4%
Global-E Online
Market Cap: US$5.5b
Provides direct-to-consumer cross-border e-commerce platform in Israel, the United Kingdom, the United States, and internationally.
GLBE
US$31.34
7D
-8.6%
1Y
1.8%
Ionis Pharmaceuticals
Market Cap: US$5.5b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$33.50
7D
2.8%
1Y
-11.8%
Nuvalent
Market Cap: US$5.4b
A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.
NUVL
US$73.66
7D
3.7%
1Y
5.5%
Axsome Therapeutics
Market Cap: US$5.3b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$105.76
7D
2.0%
1Y
37.7%
Lantheus Holdings
Market Cap: US$5.3b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$75.13
7D
-4.7%
1Y
-7.6%
Legend Biotech
Market Cap: US$5.2b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$28.33
7D
1.9%
1Y
-33.5%
Guardant Health
Market Cap: US$5.0b
A precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.
GH
US$37.09
7D
-8.9%
1Y
64.8%
ChampionX
Market Cap: US$4.8b
Provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide.
CHX
US$24.63
7D
-6.0%
1Y
-25.1%
Onto Innovation
Market Cap: US$4.8b
Engages in the design, development, manufacture, and support of process control tools that performs optical metrology and inspection worldwide.
ONTO
US$94.62
7D
-9.1%
1Y
-58.7%
Vaxcyte
Market Cap: US$4.7b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$33.97
7D
15.5%
1Y
-52.4%
Globant
Market Cap: US$4.7b
Provides technology services worldwide.
GLOB
US$102.75
7D
-23.1%
1Y
-39.8%